cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Spruce Biosciences Inc
6 own
13 watching
Current Price
$0
$-0.06
(-2.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
71.62M
52-Week High
52-Week High
3.38
52-Week Low
52-Week Low
0.9547
Average Volume
Average Volume
0.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization71.62M
icon52-Week High3.38
icon52-Week Low0.9547
iconAverage Volume0.1M
iconDividend Yield--
iconP/E Ratio--
What does the Spruce Biosciences Inc do?
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.
Read More
How much money does Spruce Biosciences Inc make?
News & Events about Spruce Biosciences Inc.
PR Newswire
25days ago
Thinking about buying stock in SWVL Holdings, Apexigen, Sonnet BioTherapeutics, Spruce Biosciences, or Tilray? Thinking about buying stock in SWVL Holdings, Apexigen, Sonnet BioTherapeutics, Spruce Biosciences, or Tilray? PR Newswire NEW YORK, Jan. 9, 2023 NEW YORK, Jan. 9, 2023 /PRNewswire...
Pharmaceutical Business Review
28days ago
As per the terms of the agreement, Spruce will get an upfront payment of $15m from Kaken. It will also be eligible to get further payments following the The post Spruce Biosciences, Kaken Pharmaceutical sign deal for tildacerfont to treat CAH appeared first on Pharmaceutical Business review...
Benzinga
28days ago
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. read more...
PR Newswire
28days ago
Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? PR Newswire NEW YORK, Jan. 6, 2023 NEW...
Ticker Report
1month ago
Relmada Therapeutics (NASDAQ:RLMD Get Rating) and Spruce Biosciences (NASDAQ:SPRB Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, ...
Frequently Asked Questions
Frequently Asked Questions
What is Spruce Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Spruce Biosciences Inc shares?
plus_minus_icon
How can I buy Spruce Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Spruce Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Spruce Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Spruce Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Spruce Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Spruce Biosciences Inc?
plus_minus_icon
What percentage is Spruce Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Spruce Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.06
(-2.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00